カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のインフルエンザ薬市場2022年：ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他

◆英語タイトル：Global Influenza Medication Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8854 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：91 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

インフルエンザ薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のインフルエンザ薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

インフルエンザ薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他

用途別セグメントは次のように区分されます。
・病院、診療所、薬局、その他

世界のインフルエンザ薬市場の主要な市場プレーヤーは以下のとおりです。
・Daiichi Sankyo Company、GlaxoSmithKline、Natco Pharma、F. Hoffmann-La Roche、Teva Pharmaceutical、Sandoz International、Sun Pharmaceutical Industries、Mylan

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、インフルエンザ薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なインフルエンザ薬メーカーの企業概要、2019年～2022年までのインフルエンザ薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なインフルエンザ薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別インフルエンザ薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのインフルエンザ薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのインフルエンザ薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびインフルエンザ薬の産業チェーンを掲載しています。
・第13、14、15章では、インフルエンザ薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Daiichi Sankyo Company、GlaxoSmithKline、Natco Pharma、F. Hoffmann-La Roche、Teva Pharmaceutical、Sandoz International、Sun Pharmaceutical Industries、Mylan
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他
・用途別分析2017年-2028年：病院、診療所、薬局、その他
・インフルエンザ薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・インフルエンザ薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・インフルエンザ薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・インフルエンザ薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・インフルエンザ薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Influenza Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Influenza Medication market size is estimated to be worth US$ 545.7 million in 2021 and is forecast to a readjusted size of USD 750.9 million by 2028 with a CAGR of 4.7% during review period. Hospitals accounting for % of the Influenza Medication global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Zanamivir segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Influenza Medication include Daiichi Sankyo Company, GlaxoSmithKline, Natco Pharma, F. Hoffmann-La Roche, and Teva Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Influenza Medication market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Market segment by Application can be divided into
Hospitals
Clinics
Pharmacies
Others
The key market players for global Influenza Medication market are listed below:
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Medication product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza Medication, with price, sales, revenue and global market share of Influenza Medication from 2019 to 2022.
Chapter 3, the Influenza Medication competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Medication breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Influenza Medication market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Medication.
Chapter 13, 14, and 15, to describe Influenza Medication sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Influenza Medication Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza Medication Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Amantadine
1.2.6 Rimantadine
1.2.7 Inosine
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza Medication Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Global Influenza Medication Market Size & Forecast
1.4.1 Global Influenza Medication Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Influenza Medication Sales in Volume (2017-2028)
1.4.3 Global Influenza Medication Price (2017-2028)
1.5 Global Influenza Medication Production Capacity Analysis
1.5.1 Global Influenza Medication Total Production Capacity (2017-2028)
1.5.2 Global Influenza Medication Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Influenza Medication Market Drivers
1.6.2 Influenza Medication Market Restraints
1.6.3 Influenza Medication Trends Analysis
2 Manufacturers Profiles
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business
2.1.3 Daiichi Sankyo Company Influenza Medication Product and Services
2.1.4 Daiichi Sankyo Company Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Influenza Medication Product and Services
2.2.4 GlaxoSmithKline Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Natco Pharma
2.3.1 Natco Pharma Details
2.3.2 Natco Pharma Major Business
2.3.3 Natco Pharma Influenza Medication Product and Services
2.3.4 Natco Pharma Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Influenza Medication Product and Services
2.4.4 F. Hoffmann-La Roche Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teva Pharmaceutical
2.5.1 Teva Pharmaceutical Details
2.5.2 Teva Pharmaceutical Major Business
2.5.3 Teva Pharmaceutical Influenza Medication Product and Services
2.5.4 Teva Pharmaceutical Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sandoz International
2.6.1 Sandoz International Details
2.6.2 Sandoz International Major Business
2.6.3 Sandoz International Influenza Medication Product and Services
2.6.4 Sandoz International Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Influenza Medication Product and Services
2.7.4 Sun Pharmaceutical Industries Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Influenza Medication Product and Services
2.8.4 Mylan Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Influenza Medication Breakdown Data by Manufacturer
3.1 Global Influenza Medication Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Influenza Medication Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Influenza Medication
3.4 Market Concentration Rate
3.4.1 Top 3 Influenza Medication Manufacturer Market Share in 2021
3.4.2 Top 6 Influenza Medication Manufacturer Market Share in 2021
3.5 Global Influenza Medication Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Influenza Medication Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Influenza Medication Market Size by Region
4.1.1 Global Influenza Medication Sales in Volume by Region (2017-2028)
4.1.2 Global Influenza Medication Revenue by Region (2017-2028)
4.2 North America Influenza Medication Revenue (2017-2028)
4.3 Europe Influenza Medication Revenue (2017-2028)
4.4 Asia-Pacific Influenza Medication Revenue (2017-2028)
4.5 South America Influenza Medication Revenue (2017-2028)
4.6 Middle East and Africa Influenza Medication Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Influenza Medication Sales in Volume by Type (2017-2028)
5.2 Global Influenza Medication Revenue by Type (2017-2028)
5.3 Global Influenza Medication Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Influenza Medication Sales in Volume by Application (2017-2028)
6.2 Global Influenza Medication Revenue by Application (2017-2028)
6.3 Global Influenza Medication Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Influenza Medication Sales by Type (2017-2028)
7.2 North America Influenza Medication Sales by Application (2017-2028)
7.3 North America Influenza Medication Market Size by Country
7.3.1 North America Influenza Medication Sales in Volume by Country (2017-2028)
7.3.2 North America Influenza Medication Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Influenza Medication Sales by Type (2017-2028)
8.2 Europe Influenza Medication Sales by Application (2017-2028)
8.3 Europe Influenza Medication Market Size by Country
8.3.1 Europe Influenza Medication Sales in Volume by Country (2017-2028)
8.3.2 Europe Influenza Medication Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Influenza Medication Sales by Type (2017-2028)
9.2 Asia-Pacific Influenza Medication Sales by Application (2017-2028)
9.3 Asia-Pacific Influenza Medication Market Size by Region
9.3.1 Asia-Pacific Influenza Medication Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Influenza Medication Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Influenza Medication Sales by Type (2017-2028)
10.2 South America Influenza Medication Sales by Application (2017-2028)
10.3 South America Influenza Medication Market Size by Country
10.3.1 South America Influenza Medication Sales in Volume by Country (2017-2028)
10.3.2 South America Influenza Medication Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Influenza Medication Sales by Type (2017-2028)
11.2 Middle East & Africa Influenza Medication Sales by Application (2017-2028)
11.3 Middle East & Africa Influenza Medication Market Size by Country
11.3.1 Middle East & Africa Influenza Medication Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Influenza Medication Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Influenza Medication and Key Manufacturers
12.2 Manufacturing Costs Percentage of Influenza Medication
12.3 Influenza Medication Production Process
12.4 Influenza Medication Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Influenza Medication Typical Distributors
13.3 Influenza Medication Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Influenza Medication Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Influenza Medication Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Company Major Business
Table 5. Daiichi Sankyo Company Influenza Medication Product and Services
Table 6. Daiichi Sankyo Company Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Influenza Medication Product and Services
Table 10. GlaxoSmithKline Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Natco Pharma Major Business
Table 13. Natco Pharma Influenza Medication Product and Services
Table 14. Natco Pharma Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 16. F. Hoffmann-La Roche Major Business
Table 17. F. Hoffmann-La Roche Influenza Medication Product and Services
Table 18. F. Hoffmann-La Roche Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Teva Pharmaceutical Major Business
Table 21. Teva Pharmaceutical Influenza Medication Product and Services
Table 22. Teva Pharmaceutical Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sandoz International Basic Information, Manufacturing Base and Competitors
Table 24. Sandoz International Major Business
Table 25. Sandoz International Influenza Medication Product and Services
Table 26. Sandoz International Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharmaceutical Industries Major Business
Table 29. Sun Pharmaceutical Industries Influenza Medication Product and Services
Table 30. Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Influenza Medication Product and Services
Table 34. Mylan Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Influenza Medication Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Influenza Medication Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Influenza Medication, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Influenza Medication Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Influenza Medication Production Site of Key Manufacturer
Table 40. Influenza Medication New Entrant and Capacity Expansion Plans
Table 41. Influenza Medication Mergers & Acquisitions in the Past Five Years
Table 42. Global Influenza Medication Sales by Region (2017-2022) & (K Units)
Table 43. Global Influenza Medication Sales by Region (2023-2028) & (K Units)
Table 44. Global Influenza Medication Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Influenza Medication Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 47. Global Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 48. Global Influenza Medication Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Influenza Medication Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Influenza Medication Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Influenza Medication Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 53. Global Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 54. Global Influenza Medication Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Influenza Medication Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Influenza Medication Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Influenza Medication Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Influenza Medication Sales by Country (2017-2022) & (K Units)
Table 59. North America Influenza Medication Sales by Country (2023-2028) & (K Units)
Table 60. North America Influenza Medication Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Influenza Medication Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 63. North America Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 64. North America Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 65. North America Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 66. Europe Influenza Medication Sales by Country (2017-2022) & (K Units)
Table 67. Europe Influenza Medication Sales by Country (2023-2028) & (K Units)
Table 68. Europe Influenza Medication Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Influenza Medication Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 71. Europe Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 72. Europe Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 73. Europe Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Influenza Medication Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Influenza Medication Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Influenza Medication Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Influenza Medication Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 82. South America Influenza Medication Sales by Country (2017-2022) & (K Units)
Table 83. South America Influenza Medication Sales by Country (2023-2028) & (K Units)
Table 84. South America Influenza Medication Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Influenza Medication Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 87. South America Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 88. South America Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 89. South America Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Influenza Medication Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Influenza Medication Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Influenza Medication Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Influenza Medication Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Influenza Medication Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Influenza Medication Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Influenza Medication Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Influenza Medication Sales by Application (2023-2028) & (K Units)
Table 98. Influenza Medication Raw Material
Table 99. Key Manufacturers of Influenza Medication Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Influenza Medication Typical Distributors
Table 103. Influenza Medication Typical Customers
List of Figures
Figure 1. Influenza Medication Picture
Figure 2. Global Influenza Medication Revenue Market Share by Type in 2021
Figure 3. Zanamivir
Figure 4. Oseltamivir
Figure 5. Peramivir
Figure 6. Amantadine
Figure 7. Rimantadine
Figure 8. Inosine
Figure 9. Others
Figure 10. Global Influenza Medication Revenue Market Share by Application in 2021
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Pharmacies
Figure 14. Others
Figure 15. Global Influenza Medication Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Influenza Medication Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Influenza Medication Sales (2017-2028) & (K Units)
Figure 18. Global Influenza Medication Price (2017-2028) & (USD/Unit)
Figure 19. Global Influenza Medication Production Capacity (2017-2028) & (K Units)
Figure 20. Global Influenza Medication Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Influenza Medication Market Drivers
Figure 22. Influenza Medication Market Restraints
Figure 23. Influenza Medication Market Trends
Figure 24. Global Influenza Medication Sales Market Share by Manufacturer in 2021
Figure 25. Global Influenza Medication Revenue Market Share by Manufacturer in 2021
Figure 26. Influenza Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Influenza Medication Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Influenza Medication Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Influenza Medication Sales Market Share by Region (2017-2028)
Figure 30. Global Influenza Medication Revenue Market Share by Region (2017-2028)
Figure 31. North America Influenza Medication Revenue (2017-2028) & (USD Million)
Figure 32. Europe Influenza Medication Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Influenza Medication Revenue (2017-2028) & (USD Million)
Figure 34. South America Influenza Medication Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Influenza Medication Revenue (2017-2028) & (USD Million)
Figure 36. Global Influenza Medication Sales Market Share by Type (2017-2028)
Figure 37. Global Influenza Medication Revenue Market Share by Type (2017-2028)
Figure 38. Global Influenza Medication Price by Type (2017-2028) & (USD/Unit)
Figure 39. Global Influenza Medication Sales Market Share by Application (2017-2028)
Figure 40. Global Influenza Medication Revenue Market Share by Application (2017-2028)
Figure 41. Global Influenza Medication Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Influenza Medication Sales Market Share by Type (2017-2028)
Figure 43. North America Influenza Medication Sales Market Share by Application (2017-2028)
Figure 44. North America Influenza Medication Sales Market Share by Country (2017-2028)
Figure 45. North America Influenza Medication Revenue Market Share by Country (2017-2028)
Figure 46. United States Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Influenza Medication Sales Market Share by Type (2017-2028)
Figure 50. Europe Influenza Medication Sales Market Share by Application (2017-2028)
Figure 51. Europe Influenza Medication Sales Market Share by Country (2017-2028)
Figure 52. Europe Influenza Medication Revenue Market Share by Country (2017-2028)
Figure 53. Germany Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Influenza Medication Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Influenza Medication Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Influenza Medication Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Influenza Medication Revenue Market Share by Region (2017-2028)
Figure 62. China Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Influenza Medication Sales Market Share by Type (2017-2028)
Figure 69. South America Influenza Medication Sales Market Share by Application (2017-2028)
Figure 70. South America Influenza Medication Sales Market Share by Country (2017-2028)
Figure 71. South America Influenza Medication Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Influenza Medication Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Influenza Medication Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Influenza Medication Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Influenza Medication Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Influenza Medication Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Influenza Medication in 2021
Figure 83. Manufacturing Process Analysis of Influenza Medication
Figure 84. Influenza Medication Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のインフルエンザ薬市場2022年：ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他(Global Influenza Medication Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のインフルエンザ薬市場2022年：ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp